drugset / Trial / NCT00915590
Topical IL-1-Ra for Treatment of Corneal Neovascularization
RandomizedCrossoverTriple-blindTreatment
Summary
The purpose of this study is to determine the effectiveness and safety of Interleukin-1-Receptor Antagonist eye drops for the treatment of corneal blood vessels.
Timeline
- Start
- 2009-04
- Primary completion
- 2011-03
- Completion
- 2011-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | IL-1Ra | Unknown | 5 % | Topical |